GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Pre-Tax Income

IMGT (XKRX:456570) Pre-Tax Income : ₩4,082.37 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. IMGT's pretax income for the six months ended in Dec. 2023 was ₩4,082.37 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,082.37 Mil. IMGT's pretax margin was 9,628.23%.

During the past 4 years, IMGT's highest Pretax Margin was 9628.23%. The lowest was -1311059.30%. And the median was 714.66%.


IMGT Pre-Tax Income Historical Data

The historical data trend for IMGT's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Pre-Tax Income Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
-6,622.87 -16,912.67 731.32 4,082.37

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Pre-Tax Income -6,622.87 -16,912.67 731.32 4,082.37

Competitive Comparison of IMGT's Pre-Tax Income

For the Biotechnology subindustry, IMGT's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMGT's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IMGT's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where IMGT's Pre-Tax Income falls into.



IMGT Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

IMGT's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6683.251+0+-2321.026+291.856+12794.79
=4,082.37

IMGT's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6683.251+0+-2321.026+291.856+12794.79
=4,082.37

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,082.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT  (XKRX:456570) Pre-Tax Income Explanation

IMGT's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=4082.369/42.4
=9,628.23%

During the past 4 years, IMGT's highest Pretax Margin was 9628.23%. The lowest was -1311059.30%. And the median was 714.66%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of IMGT's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT (XKRX:456570) Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines